Global Anti-heart Failure Drug Market Research Report to 2021

November 2016 | 109 pages | ID: G4D77E0A404EN
QYResearch

Abstracts

Notes:

Production, means the output of Anti-heart Failure Drug

Revenue, means the sales value of Anti-heart Failure Drug

This report studies Anti-heart Failure Drug in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top manufacturers in global market, with Production, price, revenue and market share for each manufacturer, covering

• Novartis
• Pfizer, Inc.
• Roche
• Sanofi
• Merck & Co., Inc.
• GlaxoSmithKline plc
• Johnson & Johnson
• AstraZeneca plc.
• Eli Lilly and Company
• Abbvie
• AMGen
• Teva Pharmaceutical Industries Ltd.
• Bayer AG
• Bristol-Myers Squibb
• Astellas Pharma
• Daiichi Sankyo
• Abbott Laboratories
• Yangtze River Pharmaceutical Group

Market Segment by Regions, this report splits Global into several key Region, with production, consumption, revenue, market share and growth rate of Anti-heart Failure Drug in these regions, from 2011 to 2021 (forecast), like

• North America
• China
• Europe
• Japan
• India
• Southeast Asia

Split by product type, with production, revenue, price, market share and growth rate of each type, can be divided into

• Cardiac Glycosides
• Phosphodiesterase Inhibitors
• Type III

Split by application, this report focuses on consumption, market share and growth rate of Anti-heart Failure Drug in each application, can be divided into

• First Level Hospital
• Two Level Hospital
• Three Level Hospital
• Others

Contents

Global Anti-heart Failure Drug Market Research Report 2021

1 ANTI-HEART FAILURE DRUG OVERVIEW

1.1 Product Overview and Scope of Anti-heart Failure Drug
1.2 Anti-heart Failure Drug Segment by Types
  1.2.1 Global Production Market Share of Anti-heart Failure Drug by Type in 2015
  1.2.2 Cardiac Glycosides Overview and Price
    1.2.2.1 Cardiac Glycosides Overview
    1.2.2.2 Cardiac Glycosides Price List in 2015 and 2016
  1.2.3 Phosphodiesterase Inhibitors
    1.2.3.1 Phosphodiesterase Inhibitors Overview
    1.2.3.2 Phosphodiesterase Inhibitors Price List in 2015 and 2016
  1.2.4 Type III
    1.2.4.1 Type I Overview
    1.2.4.2 Type I Price List in 2015 and 2016
1.3 Anti-heart Failure Drug Segment by Application
  1.3.1 Anti-heart Failure Drug Consumption Market Share by Application in 2015
  1.3.2 First Level Hospital and Major Clients (Buyers) List
  1.3.3 Two Level Hospital and Major Clients (Buyers) List
  1.3.4 Three Level Hospital and Major Clients (Buyers) List
  1.3.5 Others and Major Clients (Buyers) List
1.4 Anti-heart Failure Drug Market by Region
  1.4.1 North America Status and Prospect (2011-2021)
  1.4.2 China Status and Prospect (2011-2021)
  1.4.3 Europe Status and Prospect (2011-2021)
  1.4.4 Japan Status and Prospect (2011-2021)
  1.4.5 India Status and Prospect (2011-2021)
  1.4.6 Southeast Asia Status and Prospect (2011-2021)
1.5 Global Market Size (Value and Volume) of Anti-heart Failure Drug (2011-2021)
  1.5.1 Global Anti-heart Failure Drug Production and Revenue (2011-2021)
  1.5.2 Global Anti-heart Failure Drug Production and Growth Rate (2011-2021)
  1.5.3 Global Anti-heart Failure Drug Revenue and Growth Rate (2011-2021)

2 GLOBAL ANTI-HEART FAILURE DRUG MARKET COMPETITION BY MANUFACTURERS

2.1 Global Anti-heart Failure Drug Production and Share by Manufacturers (2015 and 2016)
2.2 Global Anti-heart Failure Drug Revenue and Share by Manufacturers (2015 and 2016)
2.3 Global Anti-heart Failure Drug Average Price by Manufacturers (2015 and 2016)
2.4 Manufacturers Anti-heart Failure Drug Manufacturing Base Distribution and Product Type
2.5 Competitive Situation and Trends
  2.5.1 Expansions
  2.5.2 New Product Launches
  2.5.3 Acquisitions
  2.5.4 Other Developments

3 GLOBAL ANTI-HEART FAILURE DRUG ANALYSIS BY REGION

3.1 Global Anti-heart Failure Drug Production, Revenue and Market Share by Region (2011-2021)
  3.1.1 Global Anti-heart Failure Drug Production Market Share by Region (2011-2021)
  3.1.2 Global Anti-heart Failure Drug Revenue Market Share by Region (2011-2021)
3.2 Global Anti-heart Failure Drug Consumption by Region (2011-2021)
3.3 North America
  3.3.1 North America Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
  3.3.2 North America Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
3.4 Europe
  3.4.1 Europe Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
  3.4.2 Europe Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
3.5 China
  3.5.1 China Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
  3.5.2 China Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
3.6 Japan
  3.6.1 Japan Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
  3.6.2 Japan Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
3.7 India
  3.7.1 India Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
  3.7.2 India Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
3.8 Southeast Asia
  3.8.1 Southeast Asia Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
  3.8.2 Southeast Asia Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)

4 GLOBAL ANTI-HEART FAILURE DRUG ANALYSIS BY TYPE

4.1 Global Anti-heart Failure Drug Production, Revenue, Market Share and Growth Rate by Type (2011-2021)
  4.1.1 Global Anti-heart Failure Drug Production and Market Share by Type (2011-2021)
  4.1.2 Global Anti-heart Failure Drug Revenue, Market Share and Growth Rate by Type (2011-2021)
4.2 Cardiac Glycosides Production, Revenue, Price and Growth (2011-2021)
4.3 Phosphodiesterase Inhibitors Production, Revenue, Price and Growth (2011-2021)
4.4 Type III Production, Revenue, Price and Growth (2011-2021)

5 GLOBAL ANTI-HEART FAILURE DRUG MARKET ANALYSIS BY APPLICATION

5.1 Global Anti-heart Failure Drug Consumption and Market Share by Application (2011-2021)
5.2 Major Regions Anti-heart Failure Drug Consumption by Application in 2015 and 2016
  5.2.1 North America Anti-heart Failure Drug Consumption by Application
  5.2.2 Europe Anti-heart Failure Drug Consumption by Application
  5.2.3 China Anti-heart Failure Drug Consumption by Application
  5.2.4 Japan Anti-heart Failure Drug Consumption by Application
  5.2.5 India Anti-heart Failure Drug Consumption by Application
  5.2.6 Southeast Asia Anti-heart Failure Drug Consumption by Application
5.3 Global Anti-heart Failure Drug Consumption Growth Rate by Application (2011-2021)
5.4 Market Drivers and Opportunities
  5.4.1 Potential Applications
  5.4.2 Emerging Markets/Countries

6 GLOBAL ANTI-HEART FAILURE DRUG MANUFACTURERS ANALYSIS

6.1 Novartis
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Anti-heart Failure Drug Product Type and Technology
    6.1.2.1 Cardiac Glycosides
    6.1.2.2 Phosphodiesterase Inhibitors
    6.1.2.3 Type III
  6.1.3 Pharmaceuticals Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.2 Pfizer, Inc.
  6.2.1 Company Basic Information, Manufacturing Base and Competitors
  6.2.2 Anti-heart Failure Drug Product Type and Technology
    6.2.2.1 Cardiac Glycosides
    6.2.2.2 Phosphodiesterase Inhibitors
    6.2.2.3 Type III
  6.2.3 Pfizer, Inc. Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.3 Roche
  6.3.1 Company Basic Information, Manufacturing Base and Competitors
  6.3.2 Anti-heart Failure Drug Product Type and Technology
    6.3.2.1 Cardiac Glycosides
    6.3.2.2 Phosphodiesterase Inhibitors
    6.3.2.3 Type III
  6.3.3 Roche Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.4 Sanofi
  6.4.1 Company Basic Information, Manufacturing Base and Competitors
  6.4.2 Anti-heart Failure Drug Product Type and Technology
    6.4.2.1 Cardiac Glycosides
    6.4.2.2 Phosphodiesterase Inhibitors
  6.4.3 Sanofi Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.5 Merck & Co., Inc.
  6.5.1 Company Basic Information, Manufacturing Base and Competitors
  6.5.2 Anti-heart Failure Drug Product Type and Technology
    6.5.2.1 Cardiac Glycosides
    6.5.2.2 Phosphodiesterase Inhibitors
  6.5.3 Merck & Co., Inc. Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.6 GlaxoSmithKline plc
  6.6.1 Company Basic Information, Manufacturing Base and Competitors
  6.6.2 Anti-heart Failure Drug Product Type and Technology
    6.6.2.1 Cardiac Glycosides
    6.6.2.2 Phosphodiesterase Inhibitors
  6.6.3 GlaxoSmithKline plc Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.7 Johnson & Johnson
  6.7.1 Company Basic Information, Manufacturing Base and Competitors
  6.7.2 Anti-heart Failure Drug Product Type and Technology
    6.7.2.1 Cardiac Glycosides
    6.7.2.2 Phosphodiesterase Inhibitors
  6.7.3 Johnson & Johnson Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.8 AstraZeneca plc.
  6.8.1 Company Basic Information, Manufacturing Base and Competitors
  6.8.2 Anti-heart Failure Drug Product Type and Technology
    6.8.2.1 Cardiac Glycosides
    6.8.2.2 Phosphodiesterase Inhibitors
  6.8.3 AstraZeneca plc. Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.9 Eli Lilly and Company
  6.9.1 Company Basic Information, Manufacturing Base and Competitors
  6.9.2 Anti-heart Failure Drug Product Type and Technology
    6.9.2.1 Cardiac Glycosides
    6.9.2.2 Phosphodiesterase Inhibitors
  6.9.3 Eli Lilly and Company Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.10 Abbvie
  6.10.1 Company Basic Information, Manufacturing Base and Competitors
  6.10.2 Anti-heart Failure Drug Product Type and Technology
    6.10.2.1 Cardiac Glycosides
    6.10.2.2 Phosphodiesterase Inhibitors
  6.10.3 Abbvie Production, Revenue, Price of Anti-heart Failure Drug (2015 and 2016)
6.11 AMGen
6.12 Teva Pharmaceutical Industries Ltd.
6.13 Bayer AG
6.14 Bristol-Myers Squibb
6.15 Astellas Pharma
6.16 Daiichi Sankyo
6.17 Abbott Laboratories
6.18 Yangtze River Pharmaceutical Group

7 ANTI-HEART FAILURE DRUG TECHNOLOGY AND DEVELOPMENT TREND

7.1 Anti-heart Failure Drug Technology Analysis
7.2 Anti-heart Failure Drug Technology Development Trend

8 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Anti-heart Failure Drug
Figure Global Production Market Share of Anti-heart Failure Drug by Type in 2015
Table Anti-heart Failure Drug Product Types of by Manufacturers
Figure Product Picture of Cardiac Glycosides
Table Cardiac Glycosides Price List in 2015 and 2016
Figure Product Picture of Phosphodiesterase Inhibitors
Table Phosphodiesterase Inhibitors Price List in 2015 and 2016
Figure Product Picture of Type III
Table Type III Price List in 2015 and 2016
Table Anti-heart Failure Drug Consumption Market Share by Applications in 2015 and 2016
Table Anti-heart Failure Drug Major Clients (Buyers) List in First Level Hospital
Table Anti-heart Failure Drug Major Clients (Buyers) List in Two Level Hospital
Table Anti-heart Failure Drug Major Clients (Buyers) List in Three Level Hospital
Table Anti-heart Failure Drug Major Clients (Buyers) List in Others
Figure North America Anti-heart Failure Drug Production and Growth Rate (2011-2021)
Figure North America Anti-heart Failure Drug Consumption and Growth Rate (2011-2021)
Figure China Anti-heart Failure Drug Production and Growth Rate (2011-2021)
Figure China Anti-heart Failure Drug Consumption and Growth Rate (2011-2021)
Figure Europe Anti-heart Failure Drug Production and Growth Rate (2011-2021)
Figure Europe Anti-heart Failure Drug Consumption and Growth Rate (2011-2021)
Figure Japan Anti-heart Failure Drug Production and Growth Rate (2011-2021)
Figure Japan Anti-heart Failure Drug Consumption and Growth Rate (2011-2021)
Figure India Anti-heart Failure Drug Production and Growth Rate (2011-2021)
Figure India Anti-heart Failure Drug Consumption and Growth Rate (2011-2021)
Figure Southeast Asia Anti-heart Failure Drug Production and Growth Rate (2011-2021)
Figure Southeast Asia Anti-heart Failure Drug Consumption and Growth Rate (2011-2021)
Table Global Anti-heart Failure Drug Production and Revenue (2011-2021)
Figure Global Anti-heart Failure Drug Production and Growth Rate (2011-2021)
Figure Global Anti-heart Failure Drug Revenue and Growth Rate (2011-2021)
Table Global Anti-heart Failure Drug Production of Key Manufacturers (2015 and 2016)
Table Global Anti-heart Failure Drug Production Share by Manufacturers (2015 and 2016)
Figure 2015 Anti-heart Failure Drug Production Share by Manufacturers
Figure 2016 Anti-heart Failure Drug Production Share by Manufacturers
Table Global Anti-heart Failure Drug Revenue by Manufacturers (2015 and 2016)
Table Global Anti-heart Failure Drug Revenue Share by Manufacturers (2015 and 2016)
Table 2015 Global Anti-heart Failure Drug Revenue Share by Manufacturers
Table 2016 Global Anti-heart Failure Drug Revenue Share by Manufacturers
Table Global Market Anti-heart Failure Drug Average Price of Key Manufacturers (2015 and 2016)
Table Manufacturers Anti-heart Failure Drug Manufacturing Base Distribution and Product Type
Table Global Anti-heart Failure Drug Production Market by Region (2011-2021)
Figure Global Anti-heart Failure Drug Production Market by Region (2011-2021)
Figure Global Anti-heart Failure Drug Production Market Share by Region (2011-2021)
Table Global Anti-heart Failure Drug Revenue Market by Region (2011-2021)
Table Global Anti-heart Failure Drug Revenue Market Share by Region (2011-2021)
Table Global Anti-heart Failure Drug Consumption Market by Region (2011-2021)
Table Global Anti-heart Failure Drug Consumption Market Share by Region (2011-2021)
Figure Global Anti-heart Failure Drug Consumption Market Share by Region (2011-2021)
Table North America Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
Figure North America Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
Table Europe Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
Figure Europe Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
Table China Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
Figure China Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
Table Japan Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
Figure Japan Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
Table India Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
Figure India Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
Table Southeast Asia Anti-heart Failure Drug Production, Revenue and Price (2011-2021)
Figure Southeast Asia Anti-heart Failure Drug Production, Revenue and Growth Rate (2011-2021)
Table Global Anti-heart Failure Drug Production by Type (2011-2021)
Table Global Anti-heart Failure Drug Production Share by Type (2011-2021)
Figure Production Market Share of Anti-heart Failure Drug by Type (2011-2021)
Figure Global Anti-heart Failure Drug Production Growth Rate by Type (2011-2021)
Table Global Anti-heart Failure Drug Revenue by Type (2011-2021)
Table Global Anti-heart Failure Drug Revenue Share by Type (2011-2021)
Figure Global Anti-heart Failure Drug Revenue Growth Rate by Type (2011-2021)
Figure Cardiac Glycosides Production, Revenue and Growth (2011-2021)
Figure Cardiac Glycosides Price Trend (2011-2021)
Figure Phosphodiesterase Inhibitors Production, Revenue and Growth (2011-2021)
Figure Phosphodiesterase Inhibitors Price Trend (2011-2021)
Figure Type III Production, Revenue and Growth (2011-2021)
Figure Type III Price Trend (2011-2021)
Table Global Anti-heart Failure Drug Consumption by Application (2011-2021)
Table Global Anti-heart Failure Drug Consumption Market Share by Application (2011-2021)
Figure Global Anti-heart Failure Drug Consumption Market Share by Application in 2015
Figure Global Anti-heart Failure Drug Consumption Market Share by Application in 2021
Table North America Anti-heart Failure Drug Consumption by Application (2015 and 2016)
Table Europe Anti-heart Failure Drug Consumption by Application (2015 and 2016)
Table China Anti-heart Failure Drug Consumption by Application (2015 and 2016)
Table Japan Anti-heart Failure Drug Consumption by Application (2015 and 2016)
Table India Anti-heart Failure Drug Consumption by Application (2015 and 2016)
Table Southeast Asia Anti-heart Failure Drug Consumption by Application (2015 and 2016)
Table Global Anti-heart Failure Drug Consumption Growth Rate by Application (2011-2021)
Figure Global Anti-heart Failure Drug Consumption Growth Rate by Application (2011-2021)
Table Novartis Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Novartis (2015 and 2016)
Table Pfizer, Inc. Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Pfizer, Inc. (2015 and 2016)
Table Roche Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Roche (2015 and 2016)
Table Sanofi Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Sanofi (2015 and 2016)
Table Merck & Co., Inc. Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Merck & Co., Inc. (2015 and 2016)
Table GlaxoSmithKline plc Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of GlaxoSmithKline plc (2015 and 2016)
Table Johnson & Johnson Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Johnson & Johnson (2015 and 2016)
Table AstraZeneca plc. Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of AstraZeneca plc. (2015 and 2016)
Table Eli Lilly and Company Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Eli Lilly and Company (2015 and 2016)
Table Abbvie Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Abbvie (2015 and 2016)
Table AMGen Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of AMGen (2015 and 2016)
Table Teva Pharmaceutical Industries Ltd. Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Teva Pharmaceutical Industries Ltd. (2015 and 2016)
Table Bayer AG Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Bayer AG (2015 and 2016)
Table Bristol-Myers Squibb Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Bristol-Myers Squibb (2015 and 2016)
Table Astellas Pharma Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Astellas Pharma (2015 and 2016)
Table Daiichi Sankyo Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Daiichi Sankyo (2015 and 2016)
Table Abbott Laboratories Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Abbott Laboratories (2015 and 2016)
Table Yangtze River Pharmaceutical Group Basic Information List
Table Anti-heart Failure Drug Production, Revenue, Price of Yangtze River Pharmaceutical Group (2015 and 2016)